Company Overview of AbGenomics Corporation
AbGenomics Corporation engages in the discovery and development of therapeutic antibodies for immune-related inflammatory diseases and cancers. It develops therapeutic antibodies for the treatment of autoimmune diseases, allergy, asthma, transplantation rejection, and cancer. The company’s products include agonistic monoclonal antibodies, humanized monoclonal antibodies, enzyme controlling insulin sensitivity and lipid metabolism, and proteins. It also provides consulting services through its subsidiary. AbGenomics Corporation was founded in 2000 and is based in Taipei, Taiwan. AbGenomics Corporation operates as a subsidiary of AbGenomics International, Inc.
2F, No. 36, Lane. 358
Founded in 2000
886 2 2627 2707
886 2 2627 2708
Key Executives for AbGenomics Corporation
AbGenomics Corporation Key Developments
Similar Private Companies By Industry
|Amaran Biotechnology, Inc.||Asia|
|Anteluo Biological Technology Co., Ltd.||Asia|
|Aviles Bio-Technology Co., Ltd.||Asia|
|Cathay Biotech Co., Ltd.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact AbGenomics Corporation, please visit www.abgenomics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.